M.E. References

Afari, N. and Buchwald, D. (2003). Chronic fatigue syndrome: a review. American Journal of Psychiatry 160:221-236.

Caliguiri, M., Murray, C., Buchwald, D., Levine, H., Cheney, P., Peterson, D., Komaroff, A.L. and Ritz, J. (1987). Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. Journal of Immunology 139:3306-3313.

Chaudhuri, A. Condon, A.J., Surtees, R.A., Lees, A.J., Adock, J.E., Harding, B., Neville, B.G. and Giovannoni, G. (2004). Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 127:21-33.

Fekety, R. (1994). Infection and chronic fatigue syndrome. In: S. Straus (editor) Chronic Fatigue Syndrome. New York, USA: Marcel Dekker.

Fukuda, K., Straus, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.G., Komaroff, A.L. and the International Chronic Fatigue Syndrome Study Group (1994). The  Chronic Fatigue Syndrome: A Comprehensive Approach to its Definition and Study. Annals of Internal Medicine 121: 953-959.

Jones, J.F., Nisenbaum, R., Solomon, L. Reyes, M. and Reeves, W.C. (2004). Chronic fatigue syndrome and other fatiguing illnesses in adolescents: a population-based study. Journal of Adolescent Health 35: 34-40.

Klimas, N.G., Salvato, F.R., Morgan, R. and Fletcher, M.A. (1990). Immunologic abnormalities in chronic fatigue syndrome. Journal of Clinical Microbiology 28:1403-1410.

Lombardi VC, Ruscetti FW, Das Gupta J.  Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome. Science. Published online October 8 2009.

Peet M., Brind J., Ramchand C.N., Shah S., Vankar G.K. Two double-blind placebocontrolled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia.

Puri, B.K., (2004) The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins, Leukotrienes and Essential Fatty Acids 70: 399-401.

Puri, B.K., Counsell, S.J., Zaman, R., Main, J., Collins, A.J., Hajnal, J.V., and Davey, N.J. (2002). Relative increase in choline in the occipital cortex in chronic fatigue syndrome. Acta Psychiatrica Scandinavica 106: 224-226.

Puri, B.K., Holmes, J and Hamilton, G. (2004). Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. International Journal of Clinical Practice 58: 297-299.

Puri, B.K., Chronic Fatigue Syndrome: A Natural Way to Treat M.E., (Hammersmith Press, London, 2005) ISBN 1-905140-00-2.

Puri, B.K. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis. Puri J Clin Pathol.2006; 0: jcp.2006.042424.